Hyaluronan synthase (HAS) and hyaluronidase mRNA levels were quantitated for the first time in ovarian cancers and normal ovaries and benign tumors, and the results correlated with hyaluronan and HAS immunocytochemistry in the corresponding tissue sections. The gene discussed is HAS1; the disease is benign neoplasm.